Altered Gut Microbiome in Parkinson's Disease and the Influence of Lipopolysaccharide in a Human α-Synuclein Over-Expressing Mouse Model.

Gammaproteobacteria Parkinson’s disease Thy1-αSyn gastrointestinal lipopolysaccharide microbiome

Journal

Frontiers in neuroscience
ISSN: 1662-4548
Titre abrégé: Front Neurosci
Pays: Switzerland
ID NLM: 101478481

Informations de publication

Date de publication:
2019
Historique:
received: 21 05 2019
accepted: 26 07 2019
entrez: 24 8 2019
pubmed: 24 8 2019
medline: 24 8 2019
Statut: epublish

Résumé

The interaction between the gut microbiota and alpha-synuclein (αSyn) aggregation in Parkinson's disease (PD) is receiving increasing attention. The objective of this study was to investigate gut microbiota, and effects of an inflammatory lipopolysaccharide (LPS) trigger in a human αSyn over-expressing mouse model of PD (Thy1-αSyn). Stool samples from patients with confirmed PD and Thy1-αSyn mice were analyzed using 16S ribosomal RNA sequencing. Compared to healthy controls, the relative abundance of mucin-degrading Verrucomicrobiae and LPS-producing Gammaproteobacteria were greater in PD patients. In mice, the abundance of Gammaproteobacteria was negligible in both Thy1-αSyn and wild-type (WT) animals, while Verrucomicrobiae were reduced in Thy1-αSyn mice. The effect of LPS on intestinal barrier function was investigated

Identifiants

pubmed: 31440136
doi: 10.3389/fnins.2019.00839
pmc: PMC6693556
doi:

Types de publication

Journal Article

Langues

eng

Pagination

839

Références

J Infect Dis. 1999 May;179(5):1278-82
pubmed: 10191237
Scand J Gastroenterol. 2002 Apr;37(4):458-66
pubmed: 11989838
Gut. 2004 May;53(5):685-93
pubmed: 15082587
Science. 2005 Jun 10;308(5728):1635-8
pubmed: 15831718
Gut. 2006 Feb;55(2):205-11
pubmed: 16188921
Neurosci Lett. 2006 Mar 20;396(1):67-72
pubmed: 16330147
Lancet Neurol. 2006 Mar;5(3):235-45
pubmed: 16488379
World J Gastroenterol. 2006 Jun 21;12(23):3729-35
pubmed: 16773690
Nature. 2006 Dec 21;444(7122):1022-3
pubmed: 17183309
Proc Natl Acad Sci U S A. 2007 Aug 21;104(34):13780-5
pubmed: 17699621
Appl Environ Microbiol. 2007 Dec;73(23):7767-70
pubmed: 17933936
Neuropathol Appl Neurobiol. 2007 Dec;33(6):599-614
pubmed: 17961138
Appl Environ Microbiol. 2008 Mar;74(5):1646-8
pubmed: 18083887
Diabetes. 2008 Jun;57(6):1470-81
pubmed: 18305141
ISME J. 2008 Jul;2(7):716-27
pubmed: 18401439
Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16731-6
pubmed: 18936492
Appl Environ Microbiol. 2009 Oct;75(20):6451-6
pubmed: 19700553
Gastroenterology. 2009 Nov;137(5):1716-24.e1-2
pubmed: 19706296
Acta Neuropathol. 2010 Jun;119(6):689-702
pubmed: 20306269
J Vis Exp. 2010 May 21;(39):null
pubmed: 20495529
Nature. 2010 Jul 15;466(7304):334-8
pubmed: 20631792
Mov Disord. 2011 Feb 15;26(3):399-406
pubmed: 21264941
Am J Physiol Gastrointest Liver Physiol. 2011 Nov;301(5):G799-807
pubmed: 21737778
Gut Microbes. 2011 May-Jun;2(3):145-58
pubmed: 21804357
Anticancer Res. 2011 Jul;31(7):2431-6
pubmed: 21873155
PLoS One. 2011;6(12):e28032
pubmed: 22145021
Mov Disord. 2012 May;27(6):771-4
pubmed: 22314772
Neurotherapeutics. 2012 Apr;9(2):297-314
pubmed: 22350713
Environ Health Perspect. 2012 Mar;120(3):340-7
pubmed: 22389202
Mol Neurobiol. 2013 Apr;47(2):561-74
pubmed: 22544647
Neurobiol Dis. 2012 Aug;47(2):258-67
pubmed: 22549133
Neurobiol Dis. 2013 Feb;50:42-8
pubmed: 23017648
Nat Rev Neurol. 2013 Jan;9(1):13-24
pubmed: 23183883
Genome Biol. 2013 Jan 24;14(1):R4
pubmed: 23347395
Gut. 2014 Jan;63(1):116-24
pubmed: 23598352
PLoS One. 2013 Sep 10;8(9):e74963
pubmed: 24040367
Parkinsonism Relat Disord. 2014 Jan;20(1):82-7
pubmed: 24120951
PLoS One. 2013 Nov 08;8(11):e78418
pubmed: 24250796
J Neurogenet. 2014 Mar-Jun;28(1-2):98-111
pubmed: 24702501
Mov Disord. 2014 Jul;29(8):999-1009
pubmed: 24898698
Parkinsonism Relat Disord. 2014 Dec;20(12):1371-5
pubmed: 25293395
Acta Neuropathol. 2014 Dec;128(6):805-20
pubmed: 25296989
Mov Disord. 2015 Mar;30(3):350-8
pubmed: 25476529
Lancet Neurol. 2015 Jun;14(6):625-39
pubmed: 25987282
Neurochem Int. 2015 Aug;87:92-105
pubmed: 26055970
Mov Disord. 2015 Sep;30(10):1351-60
pubmed: 26179554
Trends Biotechnol. 2015 Sep;33(9):496-503
pubmed: 26210164
J Neurol Neurosurg Psychiatry. 2016 Jul;87(7):710-6
pubmed: 26345189
J Immunol. 2015 Nov 15;195(10):4999-5010
pubmed: 26466961
Inflamm Bowel Dis. 2016 May;22(5):1049-55
pubmed: 26919462
Ann Neurol. 2016 Jun;79(6):940-9
pubmed: 27015771
Genome Med. 2016 Apr 27;8(1):51
pubmed: 27122046
Parkinsonism Relat Disord. 2016 Nov;32:66-72
pubmed: 27591074
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Dec;160(4):461-466
pubmed: 27812084
J Mol Neurosci. 2017 Feb;61(2):235-246
pubmed: 27866326
Cell. 2016 Dec 1;167(6):1469-1480.e12
pubmed: 27912057
Mov Disord. 2017 May;32(5):739-749
pubmed: 28195358
J Neurol Sci. 2017 Apr 15;375:86-91
pubmed: 28320196
Sci China Life Sci. 2017 Nov;60(11):1223-1233
pubmed: 28536926
Mov Disord. 2018 Jan;33(1):88-98
pubmed: 28843021
mSystems. 2017 Nov 14;2(6):null
pubmed: 29152585
Am J Pathol. 2017 Dec;187(12):2698-2710
pubmed: 29157665
Sci Rep. 2018 Jan 19;8(1):1275
pubmed: 29352191
Front Aging Neurosci. 2018 Jan 08;9:441
pubmed: 29358918
Neurotoxicology. 2018 Mar;65:174-185
pubmed: 29471018
Brain Behav Immun. 2018 May;70:48-60
pubmed: 29471030
Cell Physiol Biochem. 2018;46(5):1779-1792
pubmed: 29705796
JAMA Neurol. 2018 Aug 1;75(8):939-946
pubmed: 29710331
Inflamm Bowel Dis. 2019 Jan 1;25(1):111-123
pubmed: 29788069
Eur J Neurosci. 2019 Feb;49(3):328-338
pubmed: 30059179
Front Neurosci. 2018 Aug 30;12:612
pubmed: 30214392
Neurobiol Dis. 2018 Dec 21;:null
pubmed: 30579705
J Occup Med. 1973 Feb;15(2):101-9
pubmed: 4631080
Gut. 1995 Jan;36(1):93-9
pubmed: 7890244
J Cell Physiol. 1997 Jun;171(3):284-90
pubmed: 9180897

Auteurs

Anastazja M Gorecki (AM)

Perron Institute for Neurological and Translational Science, Nedlands, WA, Australia.
Centre for Neuromuscular & Neurological Disorders, The University of Western Australia, Crawley, WA, Australia.

Leah Preskey (L)

Ozgene Pty Ltd., Bentley, WA, Australia.
School of Medicine, The University of Notre Dame Australia, Fremantle, WA, Australia.

Megan C Bakeberg (MC)

Perron Institute for Neurological and Translational Science, Nedlands, WA, Australia.
Centre for Neuromuscular & Neurological Disorders, The University of Western Australia, Crawley, WA, Australia.

Jade E Kenna (JE)

Perron Institute for Neurological and Translational Science, Nedlands, WA, Australia.
Centre for Neuromuscular & Neurological Disorders, The University of Western Australia, Crawley, WA, Australia.

Christi Gildenhuys (C)

Perron Institute for Neurological and Translational Science, Nedlands, WA, Australia.
Institute for Health Research and School of Health Sciences, The University of Notre Dame Australia, Fremantle, WA, Australia.

Gabriella MacDougall (G)

Perron Institute for Neurological and Translational Science, Nedlands, WA, Australia.
Institute for Health Research and School of Health Sciences, The University of Notre Dame Australia, Fremantle, WA, Australia.

Sarah A Dunlop (SA)

Perron Institute for Neurological and Translational Science, Nedlands, WA, Australia.
School of Biological Sciences, The University of Western Australia, Nedlands, WA, Australia.

Frank L Mastaglia (FL)

Perron Institute for Neurological and Translational Science, Nedlands, WA, Australia.
Centre for Neuromuscular & Neurological Disorders, The University of Western Australia, Crawley, WA, Australia.

P Anthony Akkari (PA)

Perron Institute for Neurological and Translational Science, Nedlands, WA, Australia.
Centre for Neuromuscular & Neurological Disorders, The University of Western Australia, Crawley, WA, Australia.
The Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Murdoch, WA, Australia.

Frank Koengten (F)

Ozgene Pty Ltd., Bentley, WA, Australia.
School of Medicine, The University of Notre Dame Australia, Fremantle, WA, Australia.

Ryan S Anderton (RS)

Perron Institute for Neurological and Translational Science, Nedlands, WA, Australia.
Centre for Neuromuscular & Neurological Disorders, The University of Western Australia, Crawley, WA, Australia.
Institute for Health Research and School of Health Sciences, The University of Notre Dame Australia, Fremantle, WA, Australia.

Classifications MeSH